Related content

Endocrinology. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

By Ludwig M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2437-2441

Oxford University Press

Access to resources Recommend Favorite

Timing of human chorionic gonadotropin trigger, in patients undergoing controlled ovarian hyperstimulation for IVF, using the GnRH antagonist protocol

By Orvieto Raoul  

Human Fertility, Vol. 15, Iss. 4, 2012-12 ,pp. : 221-221

Informa Healthcare

Access to resources Recommend Favorite

Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation

By Orvieto Raoul   Zagatsky Irina   Yulzari-Roll Vered   la Marca Antonio   Fisch Benjamin  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 437-440

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of interleukin-6, interleukin-1ββ and human chorionic gonadotropin in pre-eclamptic and normal pregnancy

By Casart Ysabel C.   Tarrazzi Katiuska   Camejo Maríía I.  

Gynecological Endocrinology, Vol. 23, Iss. 5, 2007-08 ,pp. : 300-303

Informa Healthcare

Access to resources Recommend Favorite

Serum and follicular fluid levels of IGF-II, IGF-binding protein-4 and pregnancy-associated plasma protein-A in controlled ovarian hyperstimulation cycle between polycystic ovarian syndrome (PCOS) and non-PCOS women

By Zhong Gang   Chen Biheng  

Gynecological Endocrinology, Vol. 27, Iss. 2, 2011-02 ,pp. : 86-90

Informa Healthcare

Access to resources Recommend Favorite